[1] | Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. 2011. Pre-eclampsia: pathophysiology, diagnosis, and Management. Vascular Health Risk Managment 7:467-74. |
[2] | Roberts CT. 2010. IFPA Award in Placentology Lecture: Complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta 31:S47-53. |
[3] | Sibai BM. 2003. Diagnosis and management of gestational hypertension and preeclampsia. Obstetric and Gynecology 102: 181-192. |
[4] | Roberts JM, Hubel CA. 2009. The two stage model of preeclampsia: variations on the theme. Placenta 30: 32-37. |
[5] | Silasi M, Cohen B, Karumanchi SA, Rana S. 2010. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
Obstetrics and Gynecology Clinics of North America 37:239-253. |
[6] | Roberts JM, Hubel CA. 2009. The two stage model of preeclampsia: variations on the theme.
Placenta 30: S32-37. |
[7] | Norwitz ER. 2006. Defective implantation and placentation: laying the blueprint for pregnancy complications.
Reproductive Biomedicine Online 13:591-599. |
[8] | Goldman-Wohl D, Yagel S. 2002. Regulation of trophoblast invasion: from normal implantation to pre-eclampsia.
Molecular and Cellular Endocrinology 187:233-238. |
[9] | Kaufmann P, Black S, Huppertz B. 2003. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biology of Reproduction 69(1):1-7. |
[10] | Anton L, Merrill DC, Neves LA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB. 2008. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 51(4):1066-1072. |
[11] | Liao TD, Yang XP, Liu YH, Shesely EG, Cavasin MA, Kuziel WA, Pagano PJ, Carretero OA. 2008. Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension 52(2):256-263. |
[12] | Schiffrin EL. 2008. The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension. Hypertension 52(2):205-206. |
[13] | Williams PJ, Mistry HD, Innes BA, Bulmer JN, Pipkin FB. 2010. Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human. Placenta 31(5):448-455. |
[14] | Xia Y, Wen HY, Kellems RE. 2002. Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation. Journal of Biological Chemestry. 277(27):24601-8. |
[15] | Wallukat G, Neichel D, Nissen E, Homuth V, Luft FC. 2003. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Canadian Journal of Physiology and Pharmacology 81(2):79-8. |
[16] | Amarnani S, Sangrat B, Chaudhuri G. 1999. Effects of selected endothelium-dependent vasodilators on fetoplacental vasculature: physiological implications. American Journal of Physiology 277:842-847. |
[17] | Erices R, Corthorn J, Lisboa F, Valdés G. 2011. Bradykinin promotes migration and invasion of human immortalized trophoblasts. Reproductive Biology and Endocrinology. 9:97. |
[18] | Valdés G, Schneider D, Corthorn J, Ortiz R, Acuña S, Padilla O. 2014. Administration of angiotensin II and a bradykinin B1 receptor broker in midpregnancy impairs gestational outcome in guinea pigs. Reproductive Biology and Endocrinology 12:49. |
[19] | Myers J, Mires G, Macleod M, Baker P. 2005. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. Hypertension 45: 258-263. |
[20] | Duley L. 2006. Management of pre-eclampsia. British Medical Journal 332: 463-468. |
[21] | Abalos E, Duley L, Steyn DW, Henderson-Sart DJ. 2001. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Systematic Review 2: CD002252. |
[22] | Doering TP, Haller N, Montgomery MA, Freemn EJ, Hopkings MP. 1998. The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. American Journal of Gynecology 178: 1307-1312. |
[23] | Lamarca B, Speed J, Fournier R, Kathy Cocrell, Wallukat G, Dechend r, Granger J. 2011. Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. International Journal of Interferon Cytokine and Mediator Research 3: 65-70. |
[24] | Hering L, Herse F, Geusen N, Verlohren S, Wenzel K, Staff AC, Brosnihan KB, Huppertz B, Luft FC, Muller DN, Pijnenborg R, Cartwright JE, Dechend R. 2010. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension 56: 311-318. |
[25] | Carey RM, Wang ZQ, Siragy HM. 2000. Role of the angiotensin type 2 receptor in the regulation of blood preassure and renal function. Hypertension 35: 155-163. |
[26] | Shanmugam S, Llorens-Cortes C, Clauser E, Corvol PGase JM. 1995. Expression of angiotensin II AT2 receptor mRNA during development of the rat kidney and adrenal gland. American Journal of Physiology. 268: 922-930. |
[27] | Carey RM. 2005. Update on the role of the AT2 receptor. Current Opinions in Nephrology and Hypertension. 14: 67-71. |
[28] | Doi C, Egashira N, Kawabata A, Maurya DK, Uppalapati D, Ayuzawa R, Pickel L, Isayama Y, Troyer D, Takekoshi S, Tamura M. 2010. Angiotensin II type 2 receptor signalling significantly attenuates growth or murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer. 10: 67. |
[29] | Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S. 1993. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genetics. 4(1):59-61. |
[30] | Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ. 2010. A redox switch in angiotensinogen modulates angiotensin release. Nature 468(7320):108-111. |